Why do people take part in atrial fibrillation screening? Qualitative interview study in English primary care
- PMID: 35296474
- PMCID: PMC8928318
- DOI: 10.1136/bmjopen-2021-051703
Why do people take part in atrial fibrillation screening? Qualitative interview study in English primary care
Abstract
Objectives: There is insufficient evidence to support national screening programmes for atrial fibrillation (AF). Nevertheless, some practitioners, policy-makers and special interest groups have encouraged introduction of opportunistic screening in primary care in order to reduce the incidence of stroke through earlier detection and treatment of AF. The attitudes of the public towards AF screening are unknown. We aimed to explore why AF screening participants took part in the screening.
Design: Semistructured longitudinal interview study of participant engagement in the SAFER study (Screening for Atrial Fibrillation with ECG to Reduce stroke). We undertook initial interviews face to face, with up to two follow-up telephone interviews during the screening process. We thematically analysed and synthesised these data to understand shared views of screening participation.
Setting: 5 primary care practices in the East of England, UK.
Participants: 23 people taking part in the SAFER study first feasibility phase.
Results: Participants were supportive of screening for AF, explaining their participation in screening as a 'good thing to do'. Participants suggested screening could facilitate earlier diagnosis, more effective treatment, and a better future outcome, despite most being unfamiliar with AF. Participating in AF screening helped attenuate participants' concerns about stroke and demonstrated their commitment to self-care and being a 'good patient'. Participants felt that the screening test was non-invasive, and they were unlikely to have AF; they therefore considered engaging in AF screening was low risk, with few perceived harms.
Conclusions: Participants assessed the SAFER AF screening programme to be a legitimate, relevant and safe screening opportunity, and complied obediently with what they perceived to be a recommendation to take part. Their unreserved acceptance of screening benefit and lack of awareness of potential harms suggests that uptake would be high but reinforces the importance of ensuring participants receive balanced information about AF screening initiatives.
Trial registration number: ISRCTN16939438; Pre-results.
Keywords: cardiology; primary care; public health; qualitative research.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
Conflict of interest statement
Competing interests: JM has received honoraria from BMS/Pfizer.
Figures
Similar articles
-
Why do people choose not to take part in screening? Qualitative interview study of atrial fibrillation screening nonparticipation.Health Expect. 2023 Dec;26(6):2216-2227. doi: 10.1111/hex.13819. Epub 2023 Jul 14. Health Expect. 2023. PMID: 37452480 Free PMC article.
-
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.Health Technol Assess. 2005 Oct;9(40):iii-iv, ix-x, 1-74. doi: 10.3310/hta9400. Health Technol Assess. 2005. PMID: 16202350 Clinical Trial.
-
Feasible approaches and implementation challenges to atrial fibrillation screening: a qualitative study of stakeholder views in 11 European countries.BMJ Open. 2022 Jun 21;12(6):e059156. doi: 10.1136/bmjopen-2021-059156. BMJ Open. 2022. PMID: 35728895 Free PMC article.
-
Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation.Health Technol Assess. 2020 Jan;24(3):1-164. doi: 10.3310/hta24030. Health Technol Assess. 2020. PMID: 31933471 Free PMC article.
-
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation.Health Technol Assess. 2020 Jan;24(5):1-184. doi: 10.3310/hta24050. Health Technol Assess. 2020. PMID: 31944175 Free PMC article.
Cited by
-
Acceptability of adding a non-contrast abdominal CT scan to screen for kidney cancer and other abdominal pathology within a community-based CT screening programme for lung cancer: A qualitative study.PLoS One. 2024 Jul 1;19(7):e0300313. doi: 10.1371/journal.pone.0300313. eCollection 2024. PLoS One. 2024. PMID: 38950010 Free PMC article.
-
General practitioners' perceptions on opportunistic single-time point screening for atrial fibrillation: A European quantitative survey.Front Cardiovasc Med. 2023 Feb 15;10:1112561. doi: 10.3389/fcvm.2023.1112561. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36873407 Free PMC article.
-
Why do people choose not to take part in screening? Qualitative interview study of atrial fibrillation screening nonparticipation.Health Expect. 2023 Dec;26(6):2216-2227. doi: 10.1111/hex.13819. Epub 2023 Jul 14. Health Expect. 2023. PMID: 37452480 Free PMC article.
-
Screening for undiagnosed atrial fibrillation using a single-lead electrocardiogram at primary care visits: patient uptake and practitioner perspectives from the VITAL-AF trial.BMC Prim Care. 2023 Jun 30;24(1):135. doi: 10.1186/s12875-023-02087-5. BMC Prim Care. 2023. PMID: 37391738 Free PMC article. Clinical Trial.
-
Perceptions of healthcare professionals on the use of a risk prediction model to inform atrial fibrillation screening: qualitative interview study in English primary care.BMJ Open. 2025 Feb 5;15(2):e091675. doi: 10.1136/bmjopen-2024-091675. BMJ Open. 2025. PMID: 39909527 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical